Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2040 | 4888 | 41.2 | 82% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
96 | 73697 | DNA METHYLATION//FRAGILE X SYNDROME//RETT SYNDROME |
Classes in level below (level 1) |
ID, lev. below |
Publications | Label for level below |
---|---|---|
374 | 3497 | FRAGILE X SYNDROME//FRAGILE X//FMR1 |
6622 | 1391 | FHIT//WWOX//COMMON FRAGILE SITES |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | FRAGILE X SYNDROME | Author keyword | 1197 | 73% | 19% | 913 |
2 | FRAGILE X | Author keyword | 397 | 74% | 6% | 298 |
3 | FMR1 | Author keyword | 366 | 78% | 5% | 244 |
4 | FMRP | Author keyword | 301 | 79% | 4% | 194 |
5 | FMR1 GENE | Author keyword | 271 | 90% | 2% | 120 |
6 | FHIT | Author keyword | 218 | 74% | 3% | 164 |
7 | CGG REPEAT | Author keyword | 216 | 98% | 1% | 54 |
8 | PREMUTATION | Author keyword | 198 | 87% | 2% | 96 |
9 | WWOX | Author keyword | 180 | 87% | 2% | 90 |
10 | FXTAS | Author keyword | 151 | 81% | 2% | 92 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FRAGILE X SYNDROME | 1197 | 73% | 19% | 913 | Search FRAGILE+X+SYNDROME | Search FRAGILE+X+SYNDROME |
2 | FRAGILE X | 397 | 74% | 6% | 298 | Search FRAGILE+X | Search FRAGILE+X |
3 | FMR1 | 366 | 78% | 5% | 244 | Search FMR1 | Search FMR1 |
4 | FMRP | 301 | 79% | 4% | 194 | Search FMRP | Search FMRP |
5 | FMR1 GENE | 271 | 90% | 2% | 120 | Search FMR1+GENE | Search FMR1+GENE |
6 | FHIT | 218 | 74% | 3% | 164 | Search FHIT | Search FHIT |
7 | CGG REPEAT | 216 | 98% | 1% | 54 | Search CGG+REPEAT | Search CGG+REPEAT |
8 | PREMUTATION | 198 | 87% | 2% | 96 | Search PREMUTATION | Search PREMUTATION |
9 | WWOX | 180 | 87% | 2% | 90 | Search WWOX | Search WWOX |
10 | FXTAS | 151 | 81% | 2% | 92 | Search FXTAS | Search FXTAS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CGG REPEAT | 950 | 81% | 12% | 569 |
2 | FULL MUTATION | 598 | 92% | 5% | 241 |
3 | MENTAL RETARDATION PROTEIN | 349 | 54% | 9% | 445 |
4 | PREMUTATION | 262 | 76% | 4% | 186 |
5 | 3P142 | 254 | 82% | 3% | 149 |
6 | TREMOR ATAXIA SYNDROME FXTAS | 248 | 88% | 2% | 115 |
7 | PREMUTATION CARRIERS | 222 | 86% | 2% | 114 |
8 | FMR1 MESSENGER RNA | 220 | 85% | 2% | 117 |
9 | TREMOR ATAXIA SYNDROME | 203 | 69% | 4% | 172 |
10 | FMR1 KNOCKOUT MICE | 186 | 76% | 3% | 130 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | JOURNAL OF NEURODEVELOPMENTAL DISORDERS | 5 | 15% | 1% | 31 |
2 | AJIDD-AMERICAN JOURNAL ON INTELLECTUAL AND DEVELOPMENTAL DISABILITIES | 3 | 12% | 1% | 26 |
3 | DEVELOPMENTAL BRAIN DYSFUNCTION | 3 | 13% | 0% | 18 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Fragile X Syndrome: Loss of Local mRNA Regulation Alters Synaptic Development and Function | 2008 | 413 | 108 | 77% |
The translation of translational control by FMRP: therapeutic targets for FXS | 2013 | 54 | 93 | 73% |
Molecular Mechanisms of Fragile X Syndrome: A Twenty-Year Perspective | 2012 | 79 | 147 | 86% |
Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome | 2013 | 43 | 121 | 84% |
The Pathophysiology of Fragile X (and What It Teaches Us about Synapses) | 2012 | 98 | 181 | 70% |
WW domain-containing oxidoreductase's role in myriad cancers: Clinical significance and future implications | 2014 | 15 | 91 | 79% |
Chromosome fragile sites | 2007 | 279 | 136 | 71% |
Advances in the Treatment of Fragile X Syndrome | 2009 | 148 | 154 | 76% |
Mechanism-Based Treatments in Neurodevelopmental Disorders: Fragile X Syndrome | 2014 | 10 | 33 | 97% |
The challenges of clinical trials in fragile X syndrome | 2014 | 11 | 60 | 83% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MIND | 54 | 20% | 4.8% | 235 |
2 | CBG CLIN GENET | 45 | 80% | 0.6% | 28 |
3 | BIOCHEM MOL MED | 29 | 15% | 3.5% | 172 |
4 | FRAGILE X TREATMENT | 14 | 100% | 0.1% | 7 |
5 | MED INVEST NEURODEV DISORDERS MIND | 12 | 38% | 0.5% | 25 |
6 | IST NEUROSCI SPERIMENTALI | 12 | 86% | 0.1% | 6 |
7 | CYTOMOL DIAGNOST | 11 | 100% | 0.1% | 6 |
8 | IMMUNOL CANC IMRIC | 11 | 78% | 0.1% | 7 |
9 | BEHAV NEUROGENET NEUROIMAGING | 9 | 83% | 0.1% | 5 |
10 | INTERDISCIPLINARY BRAIN SCI | 9 | 23% | 0.7% | 34 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000021208 | RETT SYNDROME//MECP2//MECP2 GENE |
2 | 0.0000015099 | WILLIAMS SYNDROME//WILLIAMS BEUREN SYNDROME//SUPRAVALVULAR AORTIC STENOSIS |
3 | 0.0000011610 | MICROBIAL BIOTECHNOL CELL BIOL//INTERPHASE CHROMATIN//BARLEY CHROMOSOME |
4 | 0.0000011285 | PRADER WILLI SYNDROME//ANGELMAN SYNDROME//PAR 4 |
5 | 0.0000010863 | CHROMATIN SUPRAORGANIZATION//ZNF703//NUCLEAR PHENOTYPES |
6 | 0.0000010542 | RBM5//MEIOTIC DRIVE//HUMAN CHROMOSOME 3 |
7 | 0.0000010272 | COMMUNITY BASED REHABILITATION//DISABIL STUDIES PROGRAMME//ANGANWADI |
8 | 0.0000009883 | AUTISM//JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS//AUTISM SPECTRUM DISORDERS |
9 | 0.0000008232 | XIST//X CHROMOSOME INACTIVATION//TSIX |
10 | 0.0000006284 | TURNER SYNDROME//SRY//TURNERS SYNDROME |